These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
225 related articles for article (PubMed ID: 23987998)
1. The serpin solution; targeting thrombotic and thrombolytic serine proteases in inflammation. Chen H; Davids JA; Zheng D; Bryant M; Bot I; van Berckel TJ; Biessen E; Pepine C; Ryman K; Progulski-Fox A; Kesavalu L; Moyer R; McFadden G; Lucas A Cardiovasc Hematol Disord Drug Targets; 2013 Aug; 13(2):99-110. PubMed ID: 23987998 [TBL] [Abstract][Full Text] [Related]
2. Serpins, the vasculature, and viral therapeutics. Richardson J; Viswanathan K; Lucas A Front Biosci; 2006 Jan; 11():1042-56. PubMed ID: 16146796 [TBL] [Abstract][Full Text] [Related]
3. Viral SERPINS-A Family of Highly Potent Immune-Modulating Therapeutic Proteins. Varkoly K; Beladi R; Hamada M; McFadden G; Irving J; Lucas AR Biomolecules; 2023 Sep; 13(9):. PubMed ID: 37759793 [TBL] [Abstract][Full Text] [Related]
4. Siropins, novel serine protease inhibitors from gut microbiota acting on human proteases involved in inflammatory bowel diseases. Mkaouar H; Akermi N; Mariaule V; Boudebbouze S; Gaci N; Szukala F; Pons N; Marquez J; Gargouri A; Maguin E; Rhimi M Microb Cell Fact; 2016 Nov; 15(1):201. PubMed ID: 27894344 [TBL] [Abstract][Full Text] [Related]
5. Serpins for diagnosis and therapy in cancer. Zheng D; Chen H; Davids J; Bryant M; Lucas A Cardiovasc Hematol Disord Drug Targets; 2013 Aug; 13(2):123-32. PubMed ID: 23988000 [TBL] [Abstract][Full Text] [Related]
6. Fibrinolytic Serine Proteases, Therapeutic Serpins and Inflammation: Fire Dancers and Firestorms. Yaron JR; Zhang L; Guo Q; Haydel SE; Lucas AR Front Cardiovasc Med; 2021; 8():648947. PubMed ID: 33869309 [TBL] [Abstract][Full Text] [Related]
7. The serpin saga; development of a new class of virus derived anti-inflammatory protein immunotherapeutics. Lucas A; Liu L; Dai E; Bot I; Viswanathan K; Munuswamy-Ramunujam G; Davids JA; Bartee MY; Richardson J; Christov A; Wang H; Macaulay C; Poznansky M; Zhong R; Miller L; Biessen E; Richardson M; Sullivan C; Moyer R; Hatton M; Lomas DA; McFadden G Adv Exp Med Biol; 2009; 666():132-56. PubMed ID: 20054981 [TBL] [Abstract][Full Text] [Related]
8. Myxomavirus-derived serpin prolongs survival and reduces inflammation and hemorrhage in an unrelated lethal mouse viral infection. Chen H; Zheng D; Abbott J; Liu L; Bartee MY; Long M; Davids J; Williams J; Feldmann H; Strong J; Grau KR; Tibbetts S; Macaulay C; McFadden G; Thoburn R; Lomas DA; Spinale FG; Virgin HW; Lucas A Antimicrob Agents Chemother; 2013 Sep; 57(9):4114-27. PubMed ID: 23774438 [TBL] [Abstract][Full Text] [Related]
9. Serine Proteases and Chemokines in Neurotrauma: New Targets for Immune Modulating Therapeutics in Spinal Cord Injury. Beladi RN; Varkoly KS; Schutz L; Zhang L; Yaron JR; Guo Q; Burgin M; Hogue I; Tierney W; Dobrowski W; Lucas AR Curr Neuropharmacol; 2021; 19(11):1835-1854. PubMed ID: 33632104 [TBL] [Abstract][Full Text] [Related]
11. Myxoma viral serpin, Serp-1, a unique interceptor of coagulation and innate immune pathways. Viswanathan K; Liu L; Vaziri S; Dai E; Richardson J; Togonu-Bickersteth B; Vatsya P; Christov A; Lucas AR Thromb Haemost; 2006 Mar; 95(3):499-510. PubMed ID: 16525579 [TBL] [Abstract][Full Text] [Related]
12. Viral cross-class serpin inhibits vascular inflammation and T lymphocyte fratricide; a study in rodent models in vivo and human cell lines in vitro. Viswanathan K; Bot I; Liu L; Dai E; Turner PC; Togonu-Bickersteth B; Richardson J; Davids JA; Williams JM; Bartee MY; Chen H; van Berkel TJ; Biessen EA; Moyer RW; Lucas AR PLoS One; 2012; 7(9):e44694. PubMed ID: 23049756 [TBL] [Abstract][Full Text] [Related]
13. Serpins: Development for Therapeutic Applications. Lucas A; Yaron JR; Zhang L; Macaulay C; McFadden G Methods Mol Biol; 2018; 1826():255-265. PubMed ID: 30194606 [TBL] [Abstract][Full Text] [Related]
14. The under-appreciated world of the serpin family of serine proteinase inhibitors. Bouton MC; Geiger M; Sheffield WP; Irving JA; Lomas DA; Song S; Satyanarayanan RS; Zhang L; McFadden G; Lucas AR EMBO Mol Med; 2023 Jun; 15(6):e17144. PubMed ID: 37158379 [TBL] [Abstract][Full Text] [Related]
15. Neuroserpin, a thrombolytic serine protease inhibitor (serpin), blocks transplant vasculopathy with associated modification of T-helper cell subsets. Munuswamy-Ramanujam G; Dai E; Liu L; Shnabel M; Sun YM; Bartee M; Lomas DA; Lucas AR Thromb Haemost; 2010 Mar; 103(3):545-55. PubMed ID: 20135065 [TBL] [Abstract][Full Text] [Related]
16. Anti-apoptotic serpins as therapeutics in cardiovascular diseases. Kuiper J; Quax PH; Bot I Cardiovasc Hematol Disord Drug Targets; 2013 Aug; 13(2):111-22. PubMed ID: 23987999 [TBL] [Abstract][Full Text] [Related]
17. Heparin alters viral serpin, serp-1, anti-thrombolytic activity to anti-thrombotic activity. Li X; Schneider H; Peters A; Macaulay C; King E; Sun Y; Liu L; Dai E; Davids JA; McFadden G; Lucas A Open Biochem J; 2008; 2():6-15. PubMed ID: 18949070 [TBL] [Abstract][Full Text] [Related]
18. Analysis of In Vivo Serpin Functions in Models of Inflammatory Vascular Disease. Chen H; Ambadapadi S; Dai E; Liu L; Yaron JR; Zhang L; Lucas A Methods Mol Biol; 2018; 1826():157-182. PubMed ID: 30194600 [TBL] [Abstract][Full Text] [Related]
19. A critical review on marine serine protease and its inhibitors: A new wave of drugs? Barzkar N; Khan Z; Tamadoni Jahromi S; Pourmozaffar S; Gozari M; Nahavandi R Int J Biol Macromol; 2021 Feb; 170():674-687. PubMed ID: 33387547 [TBL] [Abstract][Full Text] [Related]
20. Novel scabies mite serpins inhibit the three pathways of the human complement system. Mika A; Reynolds SL; Mohlin FC; Willis C; Swe PM; Pickering DA; Halilovic V; Wijeyewickrema LC; Pike RN; Blom AM; Kemp DJ; Fischer K PLoS One; 2012; 7(7):e40489. PubMed ID: 22792350 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]